Company Name: |
Bejing Famous Pharmaceutical Technology Co., Ltd.
|
Tel: |
13331045123 |
Email: |
1963319514@qq.com |
Products Intro: |
Product Name:(S)-1-(4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl)ethan-1-amine CAS:1628106-86-4 Purity:97% Package:1g;5g;10g;25g;50g;100g;250g;500g;1kg;5kg;10kg;25kg;50kg;100kg;250kg;500kg
|
|
| (1R,3S)-1,2,2-Trimethylcyclopentane-1,3-dicarboxylic acid-(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethan-1-amine (1/2) Basic information |
Product Name: | (1R,3S)-1,2,2-Trimethylcyclopentane-1,3-dicarboxylic acid-(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethan-1-amine (1/2) | Synonyms: | (1R,3S)-1,2,2-Trimethylcyclopentane-1,3-dicarboxylic acid-(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethan-1-amine (1/2);(S)-1-(4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl)ethan-1-amine;3,4'-Bipyridine]-6-methanamine, α,4-dimethyl-2'-(trifluoromethyl)-, (αS)-;(1S)-1-[4-methyl-5-[2-(trifluoromethyl)-4-pyridyl]-2-pyridyl]ethanamine;(αS)-α,4-Dimethyl-2'-(trifluoromethyl)[3,4'-bipyridine]-6-methanamine;[3,4'-Bipyridine]-6-methanamine, α,4-dimethyl-2'-(trifluoromethyl)-, (αS)-;(1S)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethan-1-amine;(1S)-1-(4-methyl-5-(2-(trifluoromethyl)pyridin-4-yl)pyridin-2-yl)ethanamine | CAS: | 1628106-86-4 | MF: | C14H14F3N3 | MW: | 281.28 | EINECS: | | Product Categories: | | Mol File: | 1628106-86-4.mol | |
| (1R,3S)-1,2,2-Trimethylcyclopentane-1,3-dicarboxylic acid-(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethan-1-amine (1/2) Chemical Properties |
Boiling point | 343.1±42.0 °C(Predicted) | density | 1.232±0.06 g/cm3(Predicted) | pka | 8.73±0.50(Predicted) | CAS DataBase Reference | 1628106-86-4 |
| (1R,3S)-1,2,2-Trimethylcyclopentane-1,3-dicarboxylic acid-(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethan-1-amine (1/2) Usage And Synthesis |
Uses | (αS)-α,4-Dimethyl-2''-(trifluoromethyl)[3,4''-bipyridine]-6-methanamine is a compound involved in the discovery and evaluation of the clinical candidate IDH305, a brain penetrant mutant 1DH1 inhibitor. |
| (1R,3S)-1,2,2-Trimethylcyclopentane-1,3-dicarboxylic acid-(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethan-1-amine (1/2) Preparation Products And Raw materials |
|